| Dr Thomas Arnold Curtis, PHD, LMFT | |
|
82-6011 Napoopoo Rd, Captain Cook, HI 96704-8212 | |
| (808) 936-5882 | |
| Not Available |
| Full Name | Dr Thomas Arnold Curtis |
|---|---|
| Gender | Male |
| Speciality | Marriage & Family Therapist |
| Location | 82-6011 Napoopoo Rd, Captain Cook, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487168266 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 18 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Arnold Curtis, PHD, LMFT 131 Kuleana Loop, Hilo, HI 96720-3422 Ph: (808) 936-5882 | Dr Thomas Arnold Curtis, PHD, LMFT 82-6011 Napoopoo Rd, Captain Cook, HI 96704-8212 Ph: (808) 936-5882 |
News Archive
Breckenridge Pharmaceutical, Inc. announced today that it has completed its acquisition of certain Cypress Pharmaceutical, Inc. product assets from Pernix Therapeutics. The assets include 11 Abbreviated New Drug Applications filed with the FDA, certain ANDAs in various stages of development, as well as 6 already-approved and marketed products.
High-deductible health insurance plans are catching on in states struggling to contain escalating costs among their own employees, according to a brief the National Governors Association released Thursday. Nationally, insurance industry figures show that 13.5 million workers - public and private - are enrolled in high-deductible plans, which have soared in popularity in recent years among private sector employers trying to cope with high costs. The idea is that health costs will decline because workers will have more of an incentive to look for the best value in health care.
British researchers from Brunel University have made an astonishing discovery that could change our understanding of attention deficit, impulsivity and hyperactivity disorder (ADHD).
Researchers from the Faculty of Medicine of the University of Barcelona and the CELLEX Biomedical Research Centre from IDIBAPS have identified in a study with mice a protein which is fundamental to guarantee the restoration and regeneration of the liver after a transplant or hepatic surgery.
Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).
› Verified 7 days ago
Mrs. Lucinda Evans Faison-olsen, MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 87-3213 Ama Rd, Captain Cook, HI 96704 Phone: 808-854-1884 Fax: 808-328-9234 |